' Unprecedented ' 73% Response Rate With Combo in Untreated RCC ' Unprecedented ' 73% Response Rate With Combo in Untreated RCC
The combination of an immunotherapy and a VEGF inhibitor for the initial treatment of advanced renal cell carcinoma yielded groundbreaking results. And it is not intolerably toxic.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
More News: Cancer & Oncology | Carcinoma | Health | Hematology | Immunotherapy | Kidney Cancer | Renal Cell Carcinoma | Toxicology